Consensus recommendations on pathologic changes in the hippocampus: a postmortem multicenter inter-rater study

Tuomas Rauramaa1, Maria Pikkarainen, Elisabet Englund

  • 1Department of Pathology, Kuopio University Hospital.

Insights

Neuropathologists established consensus on diagnosing hippocampal sclerosis (HS). The term HS should specifically denote neuronal loss and gliosis, excluding microinfarction, to improve diagnostic clarity.

Area of Science:

  • Neuropathology
  • Neuroscience
  • Pathology

Background:

  • The term "hippocampal sclerosis" (HS) lacks a standardized pathologic definition, leading to diagnostic ambiguity.
  • Variability in HS diagnosis impacts research and clinical understanding of associated conditions.

Purpose of the Study:

  • To evaluate inter-rater agreement among neuropathologists for diagnosing HS.
  • To propose consensus recommendations for the consistent application of the term "HS" in neuropathologic diagnosis.

Main Methods:

  • A panel of four neuropathologists assessed 251 autopsy cases with suspected HS.
  • Cases were evaluated using hematoxylin and eosin-stained sections and descriptive definitions.
  • Immunohistochemistry was utilized to identify neurodegenerative lesions.

Main Results:

  • Initial diagnostic agreement for HS varied significantly (0%-86%), with higher agreement for vascular lesions (36%-70%).
  • A joint review emphasized the necessity of immunohistochemistry for detecting neurodegenerative changes.
  • Consensus defined HS as complete/near-complete neuronal loss and gliosis in the cornu Ammonis, excluding microinfarction.

Conclusions:

  • The term "HS" should be reserved for cases exhibiting specific neurodegenerative patterns.
  • Etiology of HS requires clarification as either neurodegenerative or "lacking neurodegenerative markers" (presumed hypoxic/ischemic).
  • Standardized criteria will enhance diagnostic accuracy and consistency in neuropathology.